Patent classifications
C08J2401/00
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3
The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.
BLENDED MEMBRANES FOR WATER VAPOR TRANSPORT AND METHODS FOR PREPARING SAME
Water vapor transport membranes for ERV and other water vapor transport applications are provided. The membranes include a substrate and an air impermeable selective layer coated on the substrate, the selective layer including a cellulose derivative and a sulfonated polyaryletherketone. In some embodiments the sulfonated polyaryletherketone is in a cation form and/or the selective layer includes s PEEK and CA in an s PEEK:CA (wt.:wt.) ratio in the range of about 7:3 to 2:3. Methods for making such membranes are provided. The methods include applying a coating solution/dispersion to a substrate and allowing the coating solution/dispersion to dry to form an air impermeable selective layer on the substrate, the coating solution/dispersion including a cellulose derivative and a sulfonated polyarylether ketone. In some embodiments the sulfonated polyaryletherketone is in a cation form and/or the coating solution/dispersion includes s PEEK and CA in an sPEEK:CA (wt.:wt.) ratio in the range of about 7:3 to 2:3.
POLYURETHANE FOAM, REFRIGERATOR INCLUDING THE SAME, AND METHOD OF MANUFACTURING POLYURETHANE FOAM
Embodiments of the present disclosure relate to a polyurethane foam, a refrigerator including the same, and a method of manufacturing polyurethane foam.
According with the present inventions, a refrigerator, comprising a polyurethane foam formed of a composition for preparing polyurethane, includes a cabinet; a door configured to open and close the cabinet; and a thermal insulation disposed in at least one of the cabinet and the door, wherein the thermal insulation includes a polyurethane foam-forming polyol system comprising a fiber having hydroxyl groups; and isocyanate.
Foam formed solid composite comprising nanocellulose and solid low-density particles
The present invention relates to a foam formed solid composite, comprising: a matrix phase consisting of a mixture of nanocellulose, at least one foaming agent, and optional additives, and a dispersed phase consisting of solid low-density particles having a density of less than 1.2 kg/dm.sup.3. The present invention further relates to a method and a liquid foam composition for manufacturing the solid composite.
Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit
This invention provides a preparation, composition, product, and application of a photo-coupled synergistically crosslinked hydrogel material. The preparation includes dissolving Component A including a photosensitive polymer derivative having o-nitrobenzyl phototriggers and Component B including a polymer derivative having amine or alkene (double group) or sulfhydryl group in a biocompatible medium to obtain solution A and solution B, respectively; mixing the solution A and solution B homogeneously to obtain a hydrogel precursor solution; initiating photo-coupled synergistic crosslinking under an irradiation of a UV light to form the hydrogel. The irradiation causes the o-nitrobenzyl phototriggers to generate an aldehyde group/keto group or a nitroso group to initiate photo-coupled synergetic crosslinking. The photo-coupled synergistically crosslinked hydrogel has applications in tissue engineering, regenerative medicine, 3D printing and as a carrier of cell, protein or drug.
Sustainable hybrid organic aerogels and methods and uses thereof
Highly porous, lightweight, and sustainable hybrid organic aerogels with ultra-low densities and excellent material properties and methods for preparing them are provided, including, e.g., PVA/CNF/GONS, RF/CNF/GONS, and PVA/CNF/MWCNT. The aerogels are modified to have a super-hydrophobic surface, thus leading to an extremely low swelling ratio and rate of moisture absorption.
Rubber composition, vulcanized rubber and tire manufactured using the same
The present invention provides a rubber composition that may improve fracture resistance of the resulting tire while maintaining good drainage performance, and a tire using the same. The rubber composition includes: a rubber component; and a fiber made of a hydrophilic resin. The fiber is formed with a coating layer on its surface. The coating layer is made of a resin having affinity for the rubber component.
Water- and oil-proofing composition, method for its production, article and water- and oil-proof paper
A water- and oil-proofing composition which can provide an article with high utility oil resistance is provided. A water- and oil-proofing composition comprising a fluorinated polymer comprising units based on the following monomer (a) and units based on the following monomer (b), a fatty acid ester of polyglycerin and an aqueous medium: Monomer (a): a compound represented by CH.sub.2CHR.sup.f (wherein R.sup.f is a C.sub.1-8 perfluoroalkyl group). Monomer (b): a monomer copolymerizable with the monomer (a).
Granulate of only natural constitutions; granulate for the manufacture of composable products and method for manufacturing the granulate and the products obtained therefrom
The present invention relates to biodegradable and compostable granules consisting of natural ingredients comprising starch and thickening and gelling agents and does not comprise bioplastics. According to the invention, the granules are used for producing biodegradable and preferably compostable products and articles of daily use. The present invention also relates to methods for producing the granules according to the invention, as well as methods for producing different products by using the granules according to the invention.
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.